• Enhancing the tropism of bacteria via genetically programmed biosensors

  AbstractEngineered bacteria for therapeutic applications would benefit from control mechanisms that confine the growth of the bacteria within specific tissues or regions in the body. Here we show that

  2021-07-02

• Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells

  AbstractChoroidal neovascularization induced by age-related macular degeneration and retinal neovascularization induced by diabetic retinopathy—two leading causes of blindness—are often treated using

  2021-07-02

• Droplet-based microfluidic platform for high-throughput screening of Streptomyces

  AbstractStreptomyces are one of the most important industrial microorganisms for the production of proteins and small-molecule drugs. Previously reported flow cytometry-based screening methods ca

  2021-06-23

• TRISCEND: Tricuspid Valve Replacement System Shows Early Promise

  The investigational transfemoral EVOQUE tricuspid valve replacement system (Edwards Lifesciences) significantly reduced severity of tricuspid regurgitation and improved quality of life at 30 days in t

  2021-06-23

• What the Eyes Tell You: 15 Abnormalities of the Lens

  Image of an anterior lenticonus courtesy of Daljit Singh, MBBS, MS, DSc.LenticonusAn anterior lenticonus with a forward-protruding lens (shown) may occur in association with Alport syndrome, spina bif

  2021-06-15

• CRC Screening Guidelines: 45 Is the New 50, and 85 Is the New 75

  Build a better mousetrap, and the world will beat a path to your door. Find an accurate, completely noninvasive method for colorectal cancer screening and you'll probably win the Nobel P

  2021-06-13

• Apatinib Boosts Survival in Chinese Patients With Advanced Liver Cancer

  NEW YORK (Reuters Health) - Apatinib improves both overall and progression-free survival in patients with advanced hepatocellular carcinoma that has progressed after previous treatment, according to a

  2021-06-06

• Landmark CRISPR trial shows promise against deadly disease

  The CRISPR–Cas9 complex (white and blue) can cut DNA (green), disabling genes that cause disease.Credit: Ella Maru Studio/Science Photo LibraryPreliminary results from a landmark clinical trial sugges

  2021-06-02